Feret W, Nalewajska M, Wojczynski L, Witkiewicz W, Klos P, Dziedziejko V
J Clin Med. 2021; 10(22).
PMID: 34830588
PMC: 8617922.
DOI: 10.3390/jcm10225305.
Wei L, Zhang W, Yang Y, Li D
BMJ Open. 2021; 11(4):e043436.
PMID: 33945499
PMC: 8039220.
DOI: 10.1136/bmjopen-2020-043436.
Monji F, Al-Mahmood Siddiquee A, Hashemian F
Eur J Pharmacol. 2020; 887:173561.
PMID: 32946870
PMC: 7490668.
DOI: 10.1016/j.ejphar.2020.173561.
Hendry B, Stafford N, Arnold A, Sangwaiya A, Manglam V, Rosen S
Pharmacol Res Perspect. 2020; 8(4):e00631.
PMID: 32715661
PMC: 7383088.
DOI: 10.1002/prp2.631.
Donate-Correa J, Tagua V, Ferri C, Martin-Nunez E, Hernandez-Carballo C, Urena-Torres P
J Clin Med. 2019; 8(3).
PMID: 30818852
PMC: 6463074.
DOI: 10.3390/jcm8030287.
Antimetastatic Action of Pentoxifylline, a Methyl Xanthine Derivative, Through its Effect on PKC Mediated Integrin Transport in B16F10 Melanoma Cells.
Ratheesh A, Jain M, Gude R
World J Oncol. 2017; 1(5):194-203.
PMID: 29147206
PMC: 5649797.
DOI: 10.4021/wjon252e.
Impact of different antithrombotics on the microcirculation and viability of perforator-based ischaemic skin flaps in a small animal model.
Fichter A, Ritschl L, Robitzky L, Wagenpfeil S, Mitchell D, Wolff K
Sci Rep. 2016; 6:35833.
PMID: 27767060
PMC: 5073281.
DOI: 10.1038/srep35833.
Pentoxifylline Loaded Floating Microballoons: Design, Development and Characterization.
Malik P, Nagaich U, Malik R, Gulati N
J Pharm (Cairo). 2015; 2013:107291.
PMID: 26555964
PMC: 4590787.
DOI: 10.1155/2013/107291.
Pharmacological potential of tocotrienols: a review.
Ahsan H, Ahad A, Iqbal J, Siddiqui W
Nutr Metab (Lond). 2014; 11(1):52.
PMID: 25435896
PMC: 4247006.
DOI: 10.1186/1743-7075-11-52.
Pentoxifylline and its applications in dermatology.
Hassan I, Dorjay K, Anwar P
Indian Dermatol Online J. 2014; 5(4):510-6.
PMID: 25396144
PMC: 4228656.
DOI: 10.4103/2229-5178.142528.
Synergistic radioprotection by gamma-tocotrienol and pentoxifylline: role of cAMP signaling.
Kulkarni S, Chakraborty K, Kumar K, Kao T, Hauer-Jensen M, Ghosh S
ISRN Radiol. 2014; 2013:390379.
PMID: 24959559
PMC: 4045513.
DOI: 10.5402/2013/390379.
Pentoxifylline-induced drug rash with eosinophilia and systemic symptoms (DRESS) in a patient with caffeine intolerance.
Saunderson R, Garsia R, Headley A, McCaughan G, OToole S, Strasser S
J Dermatol Case Rep. 2013; 7(3):77-81.
PMID: 24133560
PMC: 3797013.
DOI: 10.3315/jdcr.2013.1150.
Pentoxifylline attenuates ischemia/reperfusion injury to the small intestine in the rat.
Udassin R, Vromen A, Seror D, Haskel Y
Pediatr Surg Int. 2013; 11(5-6):329-33.
PMID: 24057708
DOI: 10.1007/BF00497805.
Intermittent claudication: new targets for drug development.
Brass E
Drugs. 2013; 73(10):999-1014.
PMID: 23775528
DOI: 10.1007/s40265-013-0078-3.
β-thalassemia intermedia: a clinical perspective.
Musallam K, Taher A, Rachmilewitz E
Cold Spring Harb Perspect Med. 2012; 2(7):a013482.
PMID: 22762026
PMC: 3385943.
DOI: 10.1101/cshperspect.a013482.
Monoclinic polymorph of 3,7-dimethyl-1-(5-oxohex-yl)-3,7-dihydro-1H-purine-2,6-dione.
Stepanovs D, Mishnev A
Acta Crystallogr Sect E Struct Rep Online. 2012; 67(Pt 11):o2851.
PMID: 22219894
PMC: 3247589.
DOI: 10.1107/S1600536811040232.
Unravelling the antimetastatic potential of pentoxifylline, a methylxanthine derivative in human MDA-MB-231 breast cancer cells.
Goel P, Gude R
Mol Cell Biochem. 2011; 358(1-2):141-51.
PMID: 21725843
DOI: 10.1007/s11010-011-0929-8.
Thalassaemia intermedia: an update.
Taher A, Musallam K, Cappellini M
Mediterr J Hematol Infect Dis. 2011; 1(1):e2009004.
PMID: 21415986
PMC: 3033165.
DOI: 10.4084/MJHID.2009.004.
Pentoxifylline does not improve outcome in a murine model for the multiple-organ dysfunction syndrome.
Volman T, Goris R, Hendriks T
Intensive Care Med. 2005; 31(5):701-8.
PMID: 15711975
DOI: 10.1007/s00134-005-2570-z.
Pentoxifylline (oxpentifylline). A review of its therapeutic efficacy in the management of peripheral vascular and cerebrovascular disorders.
Frampton J, Brogden R
Drugs Aging. 1995; 7(6):480-503.
PMID: 8601054
DOI: 10.2165/00002512-199507060-00007.
